QDDresearch

Mitsubishi Chemical Group Corporation MTLHY

MaterialsChemicalsJapan

Last close 35.00 USD on Nov 1, 2026, +21.1% year to date

Quant rating

Quant rating A Rank 23 of 220 in Materials
  1. Growth B 57 of 220
  2. Valuation A 16 of 220
  3. Quality B 85 of 220
  4. Revisions A 24 of 220
  5. Momentum B 56 of 220

Wall Street consensus Hold (2.58)Average target 8.72 USD −75.1%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Growth and profitability fiscal year ends March 31

Growth and profitability by fiscal year
202620252024202320225Y avg
Revenue (mil)23,33829,39228,99534,90132,689–
Revenue growth−20.6%1.4%−16.9%6.8%11.1%−4.5%
EPS (basic, normalized)0.050.210.540.500.97–
EPS growth−74.5%−60.5%9.0%−48.4%––
Gross margin28.9%29.0%26.1%26.7%28.0%27.8%
Net margin−2.2%1.0%2.7%2.1%4.5%1.6%
ROE−4.7%2.6%7.2%6.4%13.2%4.9%
Balance sheet, last quarter
Cash & short-term investments (mil)3,347
Current ratio1.57x
Long-term debt (mil)9,253
Net debt (mil)12,185
Total equity (mil)11,206
Net debt / equity1.09x
Net debt / EBITDA3.69x

Estimates and valuation

Consensus estimates and implied multiples
Sales (mil)EBITDA (mil)EPS
Fiscal yearMean est.GrowthEV/SalesMean est.GrowthEV/EBITDAMean est.GrowthP/E
2026 actual 23,338−20.6%1.0x 3,298−8.2%7.1x 0.05−74.5%640.2x
2027 25,666+10.0%0.9x 3,971+20.4%5.9x 0.72+1,211.2%48.8x
2028 26,004+1.3%0.9x 4,042+1.8%5.8x 0.73+2.5%47.6x
2029 26,441+1.7%0.9x 4,250+5.1%5.5x 0.84+14.2%41.7x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
SalesEPS
Fiscal yearEstimate (mil)1M3M6MEstimate1M3M6M
202725,6660.0%+2.3%+4.3%0.720.0%+35.3%+65.4%
202826,0040.0%+2.4%+4.2%0.730.0%+19.4%+32.7%
202926,4410.0%+2.0%+3.4%0.840.0%+9.7%+19.3%

Earnings surprises EPS beat in 1 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter endedMar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales reported (mil)1,142,0781,129,3531,112,7131,089,4801,075,859880,652918,472938,159966,7051,004,246
Sales mean (mil)1,109,8531,112,2001,148,2871,098,7171,095,538934,975918,237951,859963,672962,090
Surprise+2.9%+1.5%−3.1%−0.8%−1.8%−5.8%0.0%−1.4%+0.3%+4.4%
EPS reported11.0527.870.8912.96−10.0813.9665.70−3.46−68.8942.47
EPS mean13.8110.465.9822.411.9924.6172.5210.6910.6517.84
Surprise−20.0%+166.4%−85.1%−42.2%−606.5%−43.3%−9.4%−132.4%−746.9%+138.1%

Peer comparison Chemicals

Peers in the same industry group, by market capitalization
CompanyMarket capNet debt/EBITDANet marginP/BFY1 P/EFY2 P/EFY1 EV/EBITDAFY2 EV/EBITDA
MTLHY Mitsubishi Chemical Group Corporation10.7B3.69x−2.2%0.87x48.8x47.6x5.9x5.8x
TRYIY TORAY INDUSTRIES, INC.11.2B–3.1%0.95x––––
EVKIY Evonik Industries AG10.9B2.04x1.9%1.25x6.2x7.2x6.3x6.7x
YARIY Yara International ASA10.9B–––8.5x10.2x3.5x3.8x
ALB Albemarle Corp10.7B2.49x−13.2%1.04x8.1x8.9x5.0x5.1x
BNTGY Brenntag SE10.2B2.41x1.7%2.06x3.2x3.2x8.5x8.7x
Mean2.66x−1.7%1.23x14.9x15.4x5.8x6.0x
Median2.45x1.7%1.04x8.1x8.9x5.9x5.8x

Technical analysis

  • 1M−5.5%
  • 3M−3.4%
  • 1Y+27.1%
  • 3Y+32.6%

Financial statements in millions of USD

Income statement, Mitsubishi Chemical Group Corporation, fiscal years, most recent first
202620252024202320222021
Total revenue23,33829,39228,99534,90132,68929,427
Cost of revenue16,58920,85921,41625,56723,52621,059
Gross profit6,7498,5337,5799,3349,1638,367
Selling, general & administrative expenses5,1286,4696,1626,9487,0236,799
Research & development––––––
Interest expense (income), operating14.2−53.8−53.5−88.4−174−141
Unusual expense (income)1,382769−1651,084−2101,249
Other operating expenses35.237.4−94.414.731.331.0
Operating income1901,3121,7301,3762,492429
Net interest income (expense)−173−261−157−115−100−122
Gain (loss) on sale of assets––––––
Other non-operating income (expense)−12.2−45.816.84.2−5.1−10.4
Net income before taxes4.51,0051,5901,2652,387297
Provision for taxes10830041024466692.0
Minority interest−420−404−389−294−265−274
Equity in affiliates––––––
U.S. GAAP adjustment––––––
Net income before extraordinary items−5233007907261,456−68.3
Extraordinary items597–––––
Net income74.53007907261,456−68.3
EBIT, normalized1,5862,0271,5122,3712,1081,537
EBITDA, normalized3,2943,8673,3324,4024,1753,739
Basic EPS, normalized0.050.210.540.500.97–

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.